VOBYXA
Live / Registered — Registered (as of 30 Jun 2026)
What this means for you
Registered since 30 Jun 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 30 Jun 2032: the §71 affidavit of use).
Record
- Serial number
- 79443071
- Registration number
- 8320223
- Mark type
- Word mark
- Filed
- 09 Dec 2025
- Published for opposition
- 12 May 2026
- Registered
- 30 Jun 2026
- Next maintenance filing
- §71 affidavit of use, due by 30 Jun 2032 (grace period to 30 Dec 2032)
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Owner
- NOVARTIS AG, CH
- NOVARTIS AG, CH
- NOVARTIS AG, CH
Prosecution history
- 30 Jul 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 30 Jun 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Jun 2026 — REGISTERED-PRINCIPAL REGISTER
- 12 May 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 May 2026 — PUBLISHED FOR OPPOSITION
- 06 May 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Apr 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Mar 2026 — ASSIGNED TO EXAMINER
- 25 Mar 2026 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 25 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Mar 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Mar 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 09 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 09 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED